Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aptargroup (ATR)

Aptargroup (ATR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, has been recognized for its leadership on climate change topics by the...

ATR : 125.01 (+0.96%)
Aptar Announces 2026 Quarterly Conference Call Dates

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for...

ATR : 125.01 (+0.96%)
Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring

The integration aims to empower millions of users with deeper insights into migraine triggers through biometric signals.

ATR : 125.01 (+0.96%)
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced its participation at the 44 th Annual J.P....

ATR : 125.01 (+0.96%)
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

Novel treatment for PSVT developed with Milestone Pharmaceuticals

MIST : 2.01 (unch)
ATR : 125.01 (+0.96%)
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year

Ranked among the Top 100 Companies

ATR : 125.01 (+0.96%)
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today announced its participation at the Jefferies Global Healthcare...

ATR : 125.01 (+0.96%)
AptarGroup: Q3 Earnings Snapshot

AptarGroup: Q3 Earnings Snapshot

ATR : 125.01 (+0.96%)
Aptar Reports Third Quarter 2025 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended...

ATR : 125.01 (+0.96%)
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers

Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S Food and Drug Administration (FDA) has granted 510(k) clearance for HeroTracker ...

ATR : 125.01 (+0.96%)

Barchart Exclusives

As Taiwan Semi Hikes Its Dividend 20%, Should You Buy TSM Stock?
Taiwan Semiconductor continues to increase its payout. Is the growth sustainable? Here's what to know. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar